- Home
- ARTV vs NCSM Comparison
ARTV vs NCSM Comparison
Compare ARTV & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- NCSM
- Stock Information
- Founded
- ARTV 2019
- NCSM 2006
- Country
- ARTV United States
- NCSM United States
- Employees
- ARTV N/A
- NCSM N/A
- Industry
- ARTV
- NCSM Oilfield Services/Equipment
- Sector
- ARTV
- NCSM Energy
- Exchange
- ARTV NYSE
- NCSM Nasdaq
- Market Cap
- ARTV 61.9M
- NCSM 61.1M
- IPO Year
- ARTV 2024
- NCSM 2017
- Fundamental
- Price
- ARTV $2.08
- NCSM $31.44
- Analyst Decision
- ARTV Strong Buy
- NCSM
- Analyst Count
- ARTV 7
- NCSM 0
- Target Price
- ARTV $20.00
- NCSM N/A
- AVG Volume (30 Days)
- ARTV 215.6K
- NCSM 9.5K
- Earning Date
- ARTV 05-08-2025
- NCSM 04-30-2025
- Dividend Yield
- ARTV N/A
- NCSM N/A
- EPS Growth
- ARTV N/A
- NCSM N/A
- EPS
- ARTV N/A
- NCSM 3.27
- Revenue
- ARTV N/A
- NCSM $168,704,000.00
- Revenue This Year
- ARTV N/A
- NCSM $7.03
- Revenue Next Year
- ARTV N/A
- NCSM $5.82
- P/E Ratio
- ARTV N/A
- NCSM $9.66
- Revenue Growth
- ARTV N/A
- NCSM 18.16
- 52 Week Low
- ARTV $1.78
- NCSM $15.90
- 52 Week High
- ARTV $17.31
- NCSM $38.95
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- NCSM 52.40
- Support Level
- ARTV N/A
- NCSM $29.15
- Resistance Level
- ARTV N/A
- NCSM $32.71
- Average True Range (ATR)
- ARTV 0.00
- NCSM 1.84
- MACD
- ARTV 0.00
- NCSM 0.26
- Stochastic Oscillator
- ARTV 0.00
- NCSM 38.99
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.